September 10, 2025Archives of Gynecology and ObstetricsOpen Access

Obstacles in genetic testing for germline BRCA1/2 pathogenic mutations in patients with primary breast and ovarian cancer in Switzerland

View Full Paper

Ask AI

Bookmark

Acceptance of genetic counseling was high at 81.4%, but barriers remain in routine testing for BRCA1/2 mutations.
Recommendations from gynecologists significantly improved counseling uptake, especially when provided early in care.
Higher education levels and prior access to informational materials positively influenced patients' acceptance of genetic counseling.
Addressing systemic barriers will improve access to genetic testing and optimize treatment strategies for breast and ovarian cancer.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Retrospective analysis reveals low uptake of genetic counseling in patients with breast and ovarian cancer, suggesting systemic barriers in Switzerland.

Cite This Study

Braun et al. (2025) studied this question.

synapsesocial.com/papers/68c24236b210217d647a2dec https://doi.org/10.1007/s00404-025-08138-9

View Full Paper

Ask AI

Bookmark

Implication

Retrospective analysis reveals low uptake of genetic counseling in patients with breast and ovarian cancer, suggesting systemic barriers in Switzerland.

Obstacles in genetic testing for germline BRCA1/2 pathogenic mutations in patients with primary breast and ovarian cancer in Switzerland

Key Points

Discussion

Implication

Cite This Study

Obstacles in genetic testing for germline BRCA1/2 pathogenic mutations in patients with primary breast and ovarian cancer in Switzerland

Key Points

Discussion

Implication

Cite This Study

Keep reading

Keep reading